Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Molecular Pharmaceutics|July 26, 2012
Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeuticThommey P Thomas, Baohua Huang, Seok Ki Choi, et al.
Molecular Pharmaceutics|April 15, 2014
Avidity mechanism of dendrimer-folic acid conjugatesMallory A van Dongen, Justin E Silpe, Casey A Dougherty, et al.
ACS Chemical Biology|July 17, 2013
Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticlesJustin E Silpe, Madhuresh Sumit, Thommey P Thomas, et al.
Bioconjugate Chemistry|November 18, 2017
Photocontrolled Release of Doxorubicin Conjugated through a Thioacetal Photocage in Folate-Targeted Nanodelivery SystemsPamela T Wong, Shengzhuang Tang, Jayme Cannon, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 19, 2015
Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug ReleasePamela T Wong, Dexin Chen, Shengzhuang Tang, et al.
Biomacromolecules|February 9, 2013
Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of actionErika N Cline, Ming-Hsin Li, Seok Ki Choi, et al.
Molecular Pharmaceutics|September 16, 2014
Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding proteinMallory A van Dongen, Rahul Rattan, Justin Silpe, et al.
ACS Nano|December 25, 2012
Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surfaceSeok Ki Choi, Andrzej Myc, Justin Ezekiel Silpe, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI)R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749Daniel D Long, Scott R Armstrong, David T Beattie, et al.
Pageof 6